Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Company Description (as filed with the SEC)
We are a clinical-stage biopharmaceutical company focused on transforming the field of companion animal therapeutics by developing and commercializing novel, species-specific biologics. Biologics are therapeutic proteins derived from biological sources. As a class, biologics have transformed human medicine in recent decades and represent many of the top-selling therapies on the market today, due to advantages including a long duration of action, attractive side effect profiles and injectability. We believe these advantages will translate into significant advantages for companion animal therapeutics. Our platform technology, which we refer to as "PETization," is an algorithmic approach that enables us to rapidly create monoclonal antibodies ("mAbs"), a type of biologic, that are designed to be recognized as "self" or "native" by an animal's immune system, a property we refer to as "100% species-specificity. ... More ...
Where does NVET fit in the risk graph?
|Annual EPS Est:||$|
|Quarterly EPS Est:|